DK473988A - Fremgangsmaade til fremstilling af antigene fraktioner bestemt til paavisning af antistoffer, som roeb er en cardiovasculaer risiko, saaledes opnaaede antigene fraktioner og deres anvendelse til diagnose af en cardiovasculaer risiko - Google Patents

Fremgangsmaade til fremstilling af antigene fraktioner bestemt til paavisning af antistoffer, som roeb er en cardiovasculaer risiko, saaledes opnaaede antigene fraktioner og deres anvendelse til diagnose af en cardiovasculaer risiko

Info

Publication number
DK473988A
DK473988A DK473988A DK473988A DK473988A DK 473988 A DK473988 A DK 473988A DK 473988 A DK473988 A DK 473988A DK 473988 A DK473988 A DK 473988A DK 473988 A DK473988 A DK 473988A
Authority
DK
Denmark
Prior art keywords
fractions
anculaic
antibodies
diagnosis
procedure
Prior art date
Application number
DK473988A
Other languages
English (en)
Other versions
DK473988D0 (da
Inventor
Israel Goldstein
Francous Noel Marie
Original Assignee
Diatech Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diatech Sa filed Critical Diatech Sa
Publication of DK473988D0 publication Critical patent/DK473988D0/da
Publication of DK473988A publication Critical patent/DK473988A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Rehabilitation Therapy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK473988A 1987-08-26 1988-08-25 Fremgangsmaade til fremstilling af antigene fraktioner bestemt til paavisning af antistoffer, som roeb er en cardiovasculaer risiko, saaledes opnaaede antigene fraktioner og deres anvendelse til diagnose af en cardiovasculaer risiko DK473988A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8711946A FR2619924B1 (fr) 1987-08-26 1987-08-26 Procede de preparation de fractions antigeniques destinees a la detection d'anticorps revelateurs d'un risque cardio-vasculaire, fractions antigeniques ainsi obtenues et leur utilisation pour le diagnostic d'un risque cardio-vasculaire

Publications (2)

Publication Number Publication Date
DK473988D0 DK473988D0 (da) 1988-08-25
DK473988A true DK473988A (da) 1989-02-27

Family

ID=9354438

Family Applications (1)

Application Number Title Priority Date Filing Date
DK473988A DK473988A (da) 1987-08-26 1988-08-25 Fremgangsmaade til fremstilling af antigene fraktioner bestemt til paavisning af antistoffer, som roeb er en cardiovasculaer risiko, saaledes opnaaede antigene fraktioner og deres anvendelse til diagnose af en cardiovasculaer risiko

Country Status (6)

Country Link
US (1) US5039608A (da)
EP (1) EP0306360A1 (da)
JP (1) JPH01250064A (da)
DK (1) DK473988A (da)
FR (1) FR2619924B1 (da)
PT (1) PT88336B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281700A (en) * 1992-08-11 1994-01-25 The Regents Of The University Of California Method of recovering endothelial membrane from tissue and applications thereof
CA2330628A1 (en) 1998-05-01 1999-11-11 Queen's University At Kingston Method for diagnosing a vascular condition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343734A (en) * 1980-01-10 1982-08-10 The Children's Hospital Medical Center Protein diagnostic for atherosclerosis
US4628027A (en) * 1982-05-19 1986-12-09 Molecular Engineering Associates, Ltd. Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
US4492753A (en) * 1982-10-06 1985-01-08 Immudx, Inc. Method and means for assessment and prediction of risk of subsequent ischemic cardiac events
JPS61130238A (ja) * 1984-11-30 1986-06-18 Res Dev Corp Of Japan 動脈硬化巣認識モノクロナル抗体および反応試薬

Also Published As

Publication number Publication date
FR2619924B1 (fr) 1989-12-29
FR2619924A1 (fr) 1989-03-03
EP0306360A1 (fr) 1989-03-08
JPH01250064A (ja) 1989-10-05
PT88336A (pt) 1989-06-30
DK473988D0 (da) 1988-08-25
PT88336B (pt) 1993-09-30
US5039608A (en) 1991-08-13

Similar Documents

Publication Publication Date Title
NO915137D0 (no) Hittil ukjente antistoffer som er reaktive med humankarsinomer
DK318481A (da) Syntetisk peptid specifik antigenisk determinant og fremgangsmaade til fremstilling af antigene meneraler deraf
DK582189D0 (da) Fremgangsmaade til detektering af en specifik nucleinsyresekvens og diagnostisk testsaet til anvendelse ved fremgangsmaaden
DK198086A (da) Syntetisk peptid og fremgangsmaade til anvendelse af dette til paavisning af antistoffer mod htlv-iii, diagnosticering af aids og aids-forstadier og som vaccine mod aids og aids-forstadier
DK437188A (da) Fremgangsmaade til kryopreservering af hjerteklapper
DK646587D0 (da) Fremgangsmaade til fremstilling af et technetium-99m-maerket organspecifikt stof, et ved fremstillingen egnet testkit, samt diagnostikum indeholdende det maerkede stof
IT1197431B (it) Antigene anti-malarico, procedimento per la sua preparazione e vaccino che lo contiene
DE3872754D1 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
NO872174L (no) Fremgangsmaate for fremstilling av polypeptidpreparater med oekt biologisk tilgjengelighet.
DE3689948D1 (de) Monoklonale antikörper und testverfahren.
NO881215L (no) Fremgangsmaate for fremstilling av alger med forbedrete biologiske virkninger.
NO177463C (no) STLV-III-beslektede polypeptider, diagnostiske prövesett og in vitro analysefremgangsmåte for påvisning av anti-HIV-2-antistoffer i kroppsvæskepröve
DK473988D0 (da) Fremgangsmaade til fremstilling af antigene fraktioner bestemt til paavisning af antistoffer, som roeb er en cardiovasculaer risiko, saaledes opnaaede antigene fraktioner og deres anvendelse til diagnose af en cardiovasculaer risiko
DK331688D0 (da) Apparat til undersoegelse af leverfunktionen
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
DK517187D0 (da) Kobling samt fremgangsmaade til fremstilling af en saadan kobling for et roerformet organ, der omfatter en forstaerkningsarmering
NO883626L (no) Fremgangsmaate for diagnose av kikhoste og testsett for utfoerelse av fremgangsmaaten.
ES539638A0 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
DK70488D0 (da) Fremgangsmaade til paavisning af antistoffer i blod, samt membran og test-saet til anvendelse ved udoevelse af fremgangsmaaden
DK120789A (da) 4-pentafluorphenoxupiperidiner, en fremgangsmaade til deres fremstilling og anvendelse af disse som laegemiddel
SE8803062L (sv) Sekvensiella polypeptider med immunologisk aktivitet
DK407288D0 (da) Apparat til bestemmelse af en blodproeves blodtype
ZA903854B (en) Diagnostic test for detecting antibodies directed against antigens of one or more related viruses
DE3788424D1 (de) Testverfahren des menschlichen b-lymphotropen virus (hblv).
DK545687A (da) Anti-idiotype antistoffer, fremgangsmaade til deres fremstilling samt analysefremgangsmaader med udnyttelse af disse antistoffer

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment